188 related articles for article (PubMed ID: 32736531)
21. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
[TBL] [Abstract][Full Text] [Related]
22. The role of carbon adsorbent in the conservative management of chronic kidney disease.
Niwa T
Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
[TBL] [Abstract][Full Text] [Related]
23. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
[TBL] [Abstract][Full Text] [Related]
24. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
Atoh K; Itoh H; Haneda M
Diabetes Res Clin Pract; 2009 Feb; 83(2):220-6. PubMed ID: 19027976
[TBL] [Abstract][Full Text] [Related]
25. Association between Serum Indoxyl Sulfate Levels and Endothelial Function in Non-Dialysis Chronic Kidney Disease.
Wang CH; Lai YH; Kuo CH; Lin YL; Tsai JP; Hsu BG
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614554
[TBL] [Abstract][Full Text] [Related]
26. How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH-controlled releasing capsule.
Liu WS; Liang SS; Cheng MM; Wu MT; Li SY; Cheng TT; Liu TY; Tsai CY; Lai YT; Lin CH; Wang HT; Tsou HH
Environ Toxicol; 2024 Jul; 39(7):3930-3943. PubMed ID: 38572829
[TBL] [Abstract][Full Text] [Related]
27. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
[TBL] [Abstract][Full Text] [Related]
28. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
[TBL] [Abstract][Full Text] [Related]
29. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
[TBL] [Abstract][Full Text] [Related]
30. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
[TBL] [Abstract][Full Text] [Related]
31. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
[TBL] [Abstract][Full Text] [Related]
32. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.
Lin CJ; Chen HH; Pan CF; Chuang CK; Wang TJ; Sun FJ; Wu CJ
J Clin Lab Anal; 2011; 25(3):191-7. PubMed ID: 21567467
[TBL] [Abstract][Full Text] [Related]
33. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
34. Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease.
Wang L; Xiang F; Ji J; Ding X; Shen B; Chen J; Chen Y; Xue N; Zhang L; Jiang X; Cao X
Ren Fail; 2020 Nov; 42(1):1157-1163. PubMed ID: 33191829
[TBL] [Abstract][Full Text] [Related]
35. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
[TBL] [Abstract][Full Text] [Related]
36. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
[TBL] [Abstract][Full Text] [Related]
37. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
[TBL] [Abstract][Full Text] [Related]
38. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease.
Marzocco S; Dal Piaz F; Di Micco L; Torraca S; Sirico ML; Tartaglia D; Autore G; Di Iorio B
Blood Purif; 2013; 35(1-3):196-201. PubMed ID: 23485887
[TBL] [Abstract][Full Text] [Related]
39. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.
Lekawanvijit S; Kompa AR; Manabe M; Wang BH; Langham RG; Nishijima F; Kelly DJ; Krum H
PLoS One; 2012; 7(7):e41281. PubMed ID: 22829936
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.
Schulman G; Berl T; Beck GJ; Remuzzi G; Ritz E; Shimizu M; Kikuchi M; Shobu Y
Clin Exp Nephrol; 2018 Apr; 22(2):299-308. PubMed ID: 28741050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
